Participation in the study will last about 30 weeks
Enablers were familiar design elements, use on mobile devices, and stakeholder engagement
Zhong S, Li L, Shen X, Li Q, Xu W, Wang X, et al An update on lipid oxidation and inflammation in cardiovascular diseases Free Radic Biol Med
Average Weight Loss Comparison After 72 Weeks Tirzepatide (15 mg) 22.5% Tirzepatide (10 mg) 21.4% Tirzepatide (5 mg) 16.0% Placebo 2.4% These findings highlight Tirzepatides powerful impact on weight loss, making it a highly effective option for those struggling with obesity or weight-related health concerns
Many insurance plans, including Medicare and Medicaid, will cover Wegovy to prevent heart attack and stroke in people who are overweight or obese and have a diagnosis of heart disease, but not for weight loss alone